Adcock Ingram is a leading South African pharmaceutical manufacturer, listed on the Johannesburg Stock Exchange. Adcock Ingram manufactures, markets and distributes a wide range of healthcare products. The company is a leading supplier to both the private and public sectors of the market.
Adcock Ingram is a level 3 B-BBEE contributor.
We believe in ‘Adding value to life’.
Our Product Ranges
Consumer and Over-the-Counter products put the company in a leadership position in the private pharmacy market and the fast moving consumer goods (FMCG) segment.
The Prescription medicines portfolio comprises a range of quality and affordable generic medicines, with a contracted portfolio of originator medicines marketed by the division.
The Critical Care portfolio positions Adcock Ingram as a leading supplier in critical care products to the private and public sector
Capacities at the medical-grade plastics facility
The Critical Care Factory manufactures 60 fabricated components, 40 sub-assemblies and 150 local finished products (LFG’s) every day. The production capacity rates are: 117,000/day of Viaflex; 120,000/day of SVPs; 13,800/day of pour water; 5,200/day of Vacolitre; 4,200/day of blood bags; 170,000/day of unfilled bags and 3,800/day of Diasol units.
Adcock Ingram Critical Care has been a credible provider of locally manufactured blood bottles and continues to manufacture blood bags. Adcock Ingram also has well established International partnerships that to ensure the supply of blood processing equipment, Blood scales and mixes, Plasma Thawers and accessories to the South African Blood Service market.
Visit our website